I985 to I990, 67 segmental pancreas transplantations with bladder drainage were performed. Fifty were combined pancreas and kidney and 17 were pancreas after kidney transplants. All patients were transplanted with the same technique. The 1-year actuarial pancreas graft survival for the combined patients with quadruple immunosuppressive therapy was 83% and the patient survival, 95%. The most important complications were infections, leakage from the pancreatico cystostoma and vascular complications.
Introduction
All pancreas transplantations between 1985 and 1990 were performed with the same surgical technique and with few changes in the immunosuppressive protocol (Frisk et al. 1987a; Frisk et al. 1987b) , The aim of this paper was to present the survival and complication rates.
Subjects and methods

Surgical technique. A pancreas segment was placed
intraperitoneally with exoerine deviation to the urinary bladder, using a two-layer suture technique. The splenic artery and vein were anastomosed to the external iliac vessels. In patients receiving a combined pancreas and kidney, a simultaneous transplanted kidney was anastomosed extraperitoneally to the external iliac vessels on the contralateral side.
Immunosuppression. All patients received a standard triple immunosuppressive therapy with prednisolone (100 nag daily tapered to 20 mg at 3 weeks), asathioprine (1,5-2 mg/kg body weight and cyclosporin A (CyA) (8 mg/kg body weight starting day 3 or 4). The CyA concentration in peripheral blood was monitored using a monoclonal radioimmunoassay. All but six of the patients received additionM prophylactic immunosuppression with antithymocyte globulin (ATG) during the first postoperative week (quadruple therapy).
Rejection diagnosis. Clinical signs of rejection in the kidney grafts were usually verified with core needle biopsy. In the pancreas graft a rejection was suspected when urinary amylase secretion decreased or fine needle biopsy of the pancreas showed lymphoblast dominated inflammation.
Statisticalanalvsis. Survival rates were calculated using the life table method (Colton 1974) .
Results
Graft and patient survival rates
In total 67 pancreas transplantations were performed during [1985] [1986] [1987] [1988] [1989] [1990] . Fifty of these were combined pancreas and kidney(COMBI) and 17 pancreas after kidney (PAK). Patient characteristics are seen in Table 1 and the actuarial graft and patient survival for the COMBI patients in Tables 2 and 3 . Of the six patients with triple immunosuppressive therapy from the early period of our programme, two died early with functioning grafts and two died more $2 than 6 months after graft failure. Of the two patients remaining, one patient is on dialysis and the other has both transplants functioning. All but one patient in the triple therapy group have experienced rejection episodes. Of the 44 COMBI patients on quadruple immunosuppressive therapy, 34 have both transplants functioning, two have only the pancreas functioning, three only the kidney and in two patients both transplants failed. Three patients are dead, two who died with functioning grafts and one who died more than 6 months after failure of both grafts. Rejections episodes were seen in 27 of the 44 patients, 13 of them having only 1 rejection episode.
In the PAK patients the causes of graft failure were rejection (n=8), graft thrombosis (n=4) and one arterial bleeding due to a candida infection in the anastomosis. No PAK patient lost the kidney graft due to failure of the pancreas graft. One patient died of candida sepsis and pulmonary embolism 10 months after pancreas graft failure. The 1 year actuarial graft survival for 17 PAK patients was 28%.
Complications
Complications were similar in the COMBI and PAK groups, except for thrombosis of the pancreas which occurred in 24% in the PAK and 4% in the COMBI group. All complications in the COMBI group are listed in All patients with haemorrhages from the pancreas or kidney graft site were treated surgically. Other complications from the pancreas included graft pancreatitis, obstruction of the pancreas duct and excessive fluid from the pancreas wound. Among the complications from the kidney requiring surgery were lymphocele and stenosis of the ureter-bladder anastomosis. Thirty percent of the patients having complications required surgical intervention, and 15% of the patients in the COMBI group had no complication at all. The distribution of all registered complications is presented in Table 5 . 
Discussion
According to the Pancreas Registry, rejection is the most frequent cause of graft failure (Squifflet 1990) . This is consistent with our results, especially in the PAK group which has a poor graft survival rate. Rejection and graft thrombosis are the main reasons for the graft loss in the PAK group. In our material PAK patients had late rejection episodes,which was not seen in the COMBI patients. The reason for this is still
